<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Henriksen Lucas | Activity</title>
	<link>https://recash.wpsoul.net/members/eaglecover2/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/eaglecover2/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Henriksen Lucas.</description>
	<lastBuildDate>Mon, 10 Aug 2026 14:32:33 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">74f1ee297a9924f72829f0497a0db725</guid>
				<title>Henriksen Lucas posted an update: On the basis of phase 2 results, the US Food and Drug [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/168781/</link>
				<pubDate>Sun, 12 Jan 2025 11:48:02 +0000</pubDate>

									<content:encoded><![CDATA[<p>On the basis of phase 2 results, the US Food and Drug Administration granted concizumab Breakthrough Therapy designation for hemophilia B with inhibitor patients, a rare and vulnerable patient subgroup that currently has the highest unmet medical need. In the ongoing concizumab phase 3 trials, an optimized dosing regimen will be administered in&hellip;<span class="activity-read-more" id="activity-read-more-168781"><a href="https://recash.wpsoul.net/activity/p/168781/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a4f9bfaa32ec9e5e2fe14ac2e770e1a1</guid>
				<title>Henriksen Lucas posted an update: Conversely, we found a trend towards increasing REM sleep [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/157082/</link>
				<pubDate>Wed, 08 Jan 2025 11:05:40 +0000</pubDate>

									<content:encoded><![CDATA[<p>Conversely, we found a trend towards increasing REM sleep without atonia (RSWA) in subthalamic-stimulated patients and a trend towards decreased RSWA in pallidal stimulated patients. We conclude that CB-REM and RSWA might represent two distinct elements in RBD and should be assessed separately, especially in studies that report on RBD outcome&hellip;<span class="activity-read-more" id="activity-read-more-157082"><a href="https://recash.wpsoul.net/activity/p/157082/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d1ebef042203cfb9acffdfb0e53ead24</guid>
				<title>Henriksen Lucas posted an update: ations.



Longer breastfeeding duration was inversely [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/154617/</link>
				<pubDate>Tue, 07 Jan 2025 12:09:33 +0000</pubDate>

									<content:encoded><![CDATA[<p>ations.</p>
<p>Longer breastfeeding duration was inversely associated with childhood asthma and allergic diseases, and also reduced the OR of neonatal and familial risk factors on these diseases. <a href="https://www.selleckchem.com/products/blu-451.html" rel="nofollow ugc">LNG-451 price</a> Giving the prevalence of childhood asthma and allergic diseases is rapidly rising across the globe, these findings may have important clinical&hellip;<span class="activity-read-more" id="activity-read-more-154617"><a href="https://recash.wpsoul.net/activity/p/154617/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f2e5d71b7c2cc23b7a456f41fbed7b88</guid>
				<title>Henriksen Lucas became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/146290/</link>
				<pubDate>Sun, 05 Jan 2025 14:44:43 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>